Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed. This reflects a minor page version update without altering the study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-16T09:57:25.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software version change rather than any change to the trial information displayed.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:51:21.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added AA amyloidosis and multiple myeloma as related disease terms and included the Genetic and Rare Diseases Information Center as a resource.
    Difference
    0.2%
    Check dated 2026-04-03T05:47:06.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:49:02.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:26.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.